Logo image of ATCH

ATLASCLEAR HOLDINGS INC (ATCH) Stock Fundamental Analysis

NYSEARCA:ATCH - NYSE Arca - US1287452056 - Common Stock - Currency: USD

0.2558  +0 (+1.43%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ATCH. ATCH was compared to 229 industry peers in the Capital Markets industry. ATCH may be in some trouble as it scores bad on both profitability and health. ATCH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ATCH had positive earnings in the past year.
In the past year ATCH has reported a negative cash flow from operations.
ATCH Yearly Net Income VS EBIT VS OCF VS FCFATCH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M 10M

1.2 Ratios

ATCH's Return On Assets of 1.43% is on the low side compared to the rest of the industry. ATCH is outperformed by 61.57% of its industry peers.
Looking at the Return On Equity, with a value of 1.84%, ATCH is doing worse than 71.18% of the companies in the same industry.
Industry RankSector Rank
ROA 1.43%
ROE 1.84%
ROIC N/A
ROA(3y)1.34%
ROA(5y)N/A
ROE(3y)1.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATCH Yearly ROA, ROE, ROICATCH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -10 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATCH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATCH Yearly Profit, Operating, Gross MarginsATCH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, ATCH has less shares outstanding
ATCH has a worse debt/assets ratio than last year.
ATCH Yearly Shares OutstandingATCH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M 20M 25M
ATCH Yearly Total Debt VS Total AssetsATCH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -0.62, we must say that ATCH is in the distress zone and has some risk of bankruptcy.
ATCH's Altman-Z score of -0.62 is on the low side compared to the rest of the industry. ATCH is outperformed by 83.41% of its industry peers.
ATCH has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
ATCH has a better Debt to Equity ratio (0.01) than 83.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -0.62
ROIC/WACCN/A
WACCN/A
ATCH Yearly LT Debt VS Equity VS FCFATCH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

ATCH has a Current Ratio of 0.06. This is a bad value and indicates that ATCH is not financially healthy enough and could expect problems in meeting its short term obligations.
ATCH has a Current ratio of 0.06. This is amonst the worse of the industry: ATCH underperforms 92.14% of its industry peers.
ATCH has a Quick Ratio of 0.06. This is a bad value and indicates that ATCH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.06, ATCH is not doing good in the industry: 92.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
ATCH Yearly Current Assets VS Current LiabilitesATCH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ATCH have decreased strongly by -83.95% in the last year.
EPS 1Y (TTM)-83.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%184.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 3.65, the valuation of ATCH can be described as very cheap.
Based on the Price/Earnings ratio, ATCH is valued cheaply inside the industry as 96.51% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ATCH to the average of the S&P500 Index (25.05), we can say ATCH is valued rather cheaply.
Industry RankSector Rank
PE 3.65
Fwd PE N/A
ATCH Price Earnings VS Forward Price EarningsATCH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATCH Per share dataATCH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ATCH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATLASCLEAR HOLDINGS INC

NYSEARCA:ATCH (5/16/2025, 10:09:54 AM)

0.2558

+0 (+1.43%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-09 2024-08-09
Earnings (Next)N/A N/A
Inst Owners7.12%
Inst Owner Change3.6%
Ins Owners7.29%
Ins Owner Change0%
Market Cap1.60M
AnalystsN/A
Price TargetN/A
Short Float %0.67%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.65
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.04
P/tB 0.04
EV/EBITDA N/A
EPS(TTM)0.07
EY27.37%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0
BVpS6.91
TBVpS6.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.43%
ROE 1.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.34%
ROA(5y)N/A
ROE(3y)1.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -0.62
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%184.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-67.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-67.84%
OCF growth 3YN/A
OCF growth 5YN/A